FDA Approves First Muscle-Targeted Therapy for SMA

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

How Are Registries Informing Neuromuscular Disease?

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Thursday, August 7, 2025
Sponsor Information: 

This program is supported in part by an independent medical education grant from Novartis.

Faculty

Matthew Burford, MD
Assistant Professor of Neurology; Director, Neuromuscular Medicine Fellowship

The Ohio State University Medical Center

Daragh Heitzman, MD, FAAN
Director, ALS/Motor Neuron Disorder Clinic

Texas Neurology​

Michael Isfort, MD
Assistant Professor of Neurology​; Clinical Director, CMT Association Center of Excellence

The Ohio State University Wexner Medical Center

Paul Mehta, MD​
Principal Investigator

CDC National ALS Registry

Activity Overview: 

This webinar will provide updates on enrolling observational studies, and how registries are informing disease understanding, including ALS, CMT, myositis, and more. Panelists will also provide perspectives on how to support patient enrollment and share resources.